IGF2BP3介导的NTSR1 m6A甲基化增强了对虹膜素的耐药性和LUAD恶性进展

Hao Ding1, Xuan Zhu1, Yongquan Pan1

  • 1Affiliated People's Hospital of Jiangsu University, Zhenjiang, China.

概括

神经激素受体1 (NTSR1) 促进肺腺癌 (LUAD) 的进展和对义诺他干的耐药性. 它的稳定性由IGF2BP3介导的m6A甲基化增强,这表明LUAD治疗的治疗标.